Labiotech.eu

News and Trends 15 Apr 2015

AstraZeneca avoided a public crisis of its marketed diabetes treatment

Last week, FDA expressed its concerns about AstraZeneca’s treatment for type 2 diabetes, Onglyza. According to Reuters, FDA found “significant or near significant” increase of death risk. However, the agency also admits that the cause of death is multifactorial and could not be directly related to AstraZeneca’s treatment. The drug was developed as a result […]

April 15, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 15 Apr 2015

Will the roads of the future be paved with microalgae?

In contrast to first generation biofuels, where edible plants were suggested to be grown to obtain oil, microalgae raise as a very promising source alternative to fossil fuels. For the first time, they have been used to make bio-bitumen. Some French public institutes (Centre National de la Recherche Scientifique, Université de Nantes, Ecole des Mines de Nantes) in partnership […]

April 15, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 14 Apr 2015

Novacyt raised €2.2M to accelerate its technology’s launching in China

Novacyt announced a private equity placement financing of €2.2M that will be used to accelerate the launch of NOVAprep into China with its distribution partner Leica Biosystems, now scheduled for Q2 2015. This follows the successful financing of €3.1M in December 2014. This latest financing attracted support from current investors including Alto Invest, and a […]

April 14, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 13 Apr 2015

Humabs and MedImmune partnership to develop an Influenza A treatment

Medimmune starts phase I clinical trial to investigate an antibody developed under a collaboration with Humabs BioMed for the treatment of influenza A. The novel antibody developed through Humabs’ Cellclone technology will be investigated a trial being conducted by MedImmune, the global biologics research and development arm of AstraZeneca. The investigational antibody, which has broad influenza-neutralizing […]

April 13, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Apr 2015

Cardio3 Biosciences Embedded BioLife Solutions for a Heart Regenerative Therapy

Cardio3 BioSciences is again on the front page of biotech news. After announcing the launching of an IPO on Nasdaq and getting an US patent, the company has now embedded the BioLife Solutions‘ clinical grade CryoStor cryopreservation freeze media, in its ongoing Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) phase III clinical trial in Europe and Israel and the pending CHART-2 phase III clinical trial […]

April 11, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 10 Apr 2015

FuturaGene’s Genetically Modified Eucalyptus approved in Brazil

The Brazilian National Technical Commission on Biosafety (CTNBio) approved the commercial use of the yield enhanced eucalyptus developed by FuturaGene, the leading Israeli agricultural biotech. Field experiments conducted since 2006 at various locations in Brazil have demonstrated an approximate 20% increase in yield compared to its equivalent conventional variety. This is the first genetically modified […]

April 10, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 9 Apr 2015

Ipsen and Hannover Medical School start joint research in Recombinant Botulinum Neurotoxins

Ipsen and Hannover Medical School, one of the world’s leading university medical centres, have entered into a joint research collaboration agreement, signed in last September. Their objective is to develop new therapeutics for patients with serious neurological, endocrinological or oncological disease. The research program aims at testing recombinant botulinum neurotoxin proteins to affect intracellular molecular […]

April 9, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 9 Apr 2015

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

Nanomedicine could be the next revolution in healthcare and Paris-based Nanobiotix is one of the leading biotech in the field. It started from a vision in 2003 and now counts 50 employees after having raised over €70M. I had the chance to chat with Laurent Levy, founding CEO of the company, and will give you an […]

April 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 8 Apr 2015

CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War

CRISPR Therapeutics appointed Bill Lundberg to Chief Scientific Officer to lead the company’s development programs and to spearhead the creation of its R&D operations in Cambridge, Massachusetts. The biopharmaceutical company was founded in Basel, Switzerland, by Emanuelle Charpentier, one of the pioneer scientists in the CRISPR field. The company is focused on translating CRISPR-Cas9 gene-editing […]

April 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 Apr 2015

Cardio3, the leading Stem Cell Biotech gets a US patent on CAR-T

Just a week after announcing its intention to launch an IPO in the United States, Cardio3 Biosciences continues increasing its presence in the States. The company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a significant patent application broadly covering TCR-deficient T-Cells engineered to express a chimeric antigen […]

April 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 Apr 2015

A New Key Strategic Collaboration Between BMS and UniQure

Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at the forefront of the scene after having agreed on two collaborations, respectively, an agreement between Bavarian Nordic & BMS and a collaboration between Sympromics & UniQure. A few days ago, they announced an exclusive strategic collaboration to develop gene therapies for cardiovascular […]

April 7, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 7 Apr 2015

Open Bionics, lending a 3D-Printed helping hand

Little could the young Joel Gibbard have ever imagined that those Meccano games he once used to play with as a child, would one day lead him to become Britain’s Design Engineer of the Year amongst other prestigious awards. Open Bionics, the Bristol-based company he founded, aims at providing low-cost robotic hands. I got to […]

April 7, 2015 - 3 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

AstraZeneca avoided a public crisis of its marketed diabetes treatment

Will the roads of the future be paved with microalgae?

Novacyt raised €2.2M to accelerate its technology’s launching in China

Humabs and MedImmune partnership to develop an Influenza A treatment

Cardio3 Biosciences Embedded BioLife Solutions for a Heart Regenerative Therapy

FuturaGene’s Genetically Modified Eucalyptus approved in Brazil

Ipsen and Hannover Medical School start joint research in Recombinant Botulinum Neurotoxins

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

CRISPR Therapeutics opens Boston R&D Office to Win the CRISPR War

Cardio3, the leading Stem Cell Biotech gets a US patent on CAR-T

A New Key Strategic Collaboration Between BMS and UniQure

Open Bionics, lending a 3D-Printed helping hand

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!